QDA and Sidra hold second virtual meet with parents of children with type1 diabetes
The meeting was attended by QDA’s Executive Director Dr Abdullah Al Hamaq and his medical team as well as parents
QATAR Diabetes Association (QDA), a member of Qatar oundation, in collaboration with Sidra Medicine, organised the second discussion session via video-tele-communication with parents of children diagnosed with type 1 diabetes.
The meeting was attended by QDA’s Executive Director Dr Abdullah Al Hamaq and his medical team as well as parents.
The session was presented by Dr Ahmad Mohammed El Awwa, consultant, paediatric endocrinology diabetes, Sidra Medicine, and Ms Rasha Abu Raslan, treatment development specialist at Medtronic Qatar, who also addressed queries of the audience.
The webinar was characterised by great interaction as parents asked a lot of questions about the pump and how it works. The session also touched on the types of pumps and the differences between their use and the use of injections and insulin pens.
Insulin pump is a small, computerised device that mimics the way the human pancreas works by using the sugar monitor (sensor) and pump together so that the pump provides the body with insulin, according to its need when eating, or when the sugar is high. It also relieves, or stops pumping insulin to avoid hypoglycemia (low blood sugar). The speakers confirmed that so far no complete treatment has been found to cover the meal with insulin without interfering with the carbohydrates counting.
In his concluding remarks, Dr Al Hamaq thanked Dr Al-Awwa and Ms Abu Raslan Sidra for their valuable contributions, noting that the importance of continuation of such online educational meetings with the parents of children with diabetes until Qatar Diabetes Association resumes its work.